id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-1551-0016,FDA,FDA-2014-D-1551,"Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry; Draft Guidance",Other,Guidance,2020-07-30T04:00:00Z,2020,7,2020-07-30T04:00:00Z,,2024-11-06T23:38:18Z,,1,0,09000064847bd0c5
FDA-2014-D-1551-0015,FDA,FDA-2014-D-1551,"Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products—Content and Format; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2020-07-30T04:00:00Z,2020,7,2020-07-30T04:00:00Z,2020-09-29T03:59:59Z,2020-09-28T10:28:10Z,2020-16530,0,0,09000064847bdf63
FDA-2014-D-1551-0002,FDA,FDA-2014-D-1551,"Pregnancy, Lactation, and Reproductive Potential: Labeling for
Human Prescription Drug and Biological Products—Content and
Format; Draft Guidance for Industry",Other,Guidance,2014-12-05T05:00:00Z,2014,12,2014-12-05T05:00:00Z,,2024-11-12T05:34:03Z,,1,0,090000648195f0eb
FDA-2014-D-1551-0001,FDA,FDA-2014-D-1551,"Pregnancy, Lactation, and Reproductive Potential: Labeling for
Human Prescription Drug and Biological Products—Content and
Format; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2014-12-04T05:00:00Z,2014,12,2014-12-04T05:00:00Z,2015-02-03T04:59:59Z,2015-02-03T03:15:00Z,2014-28242,0,0,090000648195a5df